Tdspharm Co., Ltd. (KOSDAQ:464280)
South Korea · Delayed Price · Currency is KRW 8,280.00
+280.00 (3.50%)
Apr 8, 2026, 3:30 PM KST
Tdspharm Market Cap
Tdspharm has a market cap or net worth of 45.79 billion as of April 8, 2026. Its market cap has decreased by -39.39% in one year.
Market Cap
45.79B
Enterprise Value
33.29B
Revenue
27.62B
Ranking
n/a
PE Ratio
10.25
Stock Price
8,280.00
Market Cap Chart
Since August 21, 2024, Tdspharm's market cap has decreased from 287.56B to 45.79B, a decrease of -84.08%. That is a compound annual growth rate of -67.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 45.79B | -15.94% |
| Dec 30, 2025 | 54.47B | -25.60% |
| Dec 30, 2024 | 73.22B | -74.54% |
| Aug 21, 2024 | 287.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.98T |
| Celltrion | 42.82T |
| ALTEOGEN | 19.37T |
| Sam Chun Dang Pharm. | 14.37T |
| HASS Corp. | 55.92B |
| EOFLOW | 51.11B |
| Aprogen Biologics | 50.58B |
| IVIM Technology | 48.84B |